Physician profile
Matthew E Jones
NPI 1144468679
$2,621.37
in general payments reported to CMS, 2019-2025
15 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $140 · 2022: $1,315 · 2023: $134 · 2024: $453 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Entertainment: $97.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.64 |
| Entertainment | $97.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,625.00 | 2022-2025 | M22, Optilight |
| Biotissue Holdings INC. | $164.58 | 2021-2025 | |
| Glaukos Corporation | $127.46 | 2025 | Istent Infinite, Idosetr, Photrexa Viscous and Photrexa |
| Johnson & Johnson Vision Care, INC. | $115.60 | 2022-2024 | |
| Optos, INC. | $97.38 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $94.08 | 2021-2025 | Dailies Total1, Precision 1, Total30 |
| Sight Sciences, INC. | $88.90 | 2021 | |
| Coopervision INC. | $71.64 | 2019-2024 | Myday Contact Lens |
| Shire North American Group INC | $65.96 | 2019 | |
| Rxsight INC | $49.72 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Maculogix, INC. | $38.90 | 2019 | |
| Bausch & Lomb Americas INC. | $34.01 | 2023-2024 | Infuse |
| Sun Pharmaceutical Industries INC. | $21.82 | 2021 | |
| Allergan, INC. | $16.83 | 2022 | |
| Abb Con-Cise Optical Group LLC | $9.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.